Total Knee Replacement Aftercare Documentation: CMS HRRP Requirements, DVT Prophylaxis, and Discharge Protocols
Total knee arthroplasty (TKA) is among the highest-volume elective surgical procedures in the US and is a designated target condition under the CMS Hospital Readmissions Reduction Program (HRRP). Hospitals with excess TKA readmission rates face Medicare payment reductions of up to 3% per CMS HRRP regulations under 42 CFR 412.150 through 412.154. Discharge documentation quality directly affects 30-day readmission rates by ensuring patients have the specific, actionable instructions needed to manage pain, comply with DVT prophylaxis, progress physical therapy, and identify complications early. This guide covers CMS HRRP obligations for TKA, ACCP evidence-based DVT prophylaxis documentation requirements, wound monitoring protocols, and physical therapy progression documentation for knee replacement providers.
CMS HRRP Obligations for Total Knee Arthroplasty
CMS added total hip arthroplasty (THA) and total knee arthroplasty (TKA) to the Hospital Readmissions Reduction Program beginning with fiscal year 2015. Under 42 CFR 412.150 through 412.154, hospitals with risk-adjusted 30-day TKA readmission rates above the national benchmark face a penalty applied to all Medicare fee-for-service base payments for the applicable fiscal year. The maximum HRRP payment reduction is 3% of base Medicare payments. CMS calculates the excess readmission ratio using 3 years of discharge data, risk-adjusted for patient factors including age, sex, and comorbidities captured in Medicare claims data.
The HRRP measure for TKA captures all-cause 30-day readmissions following the index hospitalization. Per CMS measure methodology, the readmission window opens on the day of discharge from the index admission and closes 30 days later, regardless of the reason for the subsequent admission. Readmissions for any cause, including those unrelated to the surgical procedure, are counted in the measure. This design means that discharge planning quality, patient education, and post-discharge follow-up coordination are major modifiable factors in a hospital's HRRP performance for TKA.
Common diagnoses driving 30-day readmissions after TKA, based on published CMS data and peer-reviewed orthopedic literature, include surgical site complications, venous thromboembolism (VTE), periprosthetic joint infection, and cardiovascular events. Surgical site complications and infection are the most directly modifiable through discharge instruction quality, wound monitoring protocols, and timely access to post-discharge provider contact. VTE events including deep vein thrombosis (DVT) and pulmonary embolism are reduced through compliance with the DVT prophylaxis regimen prescribed at discharge, making explicit, documented prophylaxis instructions a critical discharge documentation element.
CMS offers hospitals access to their HRRP performance data through QualityNet and the Hospital Compare reporting system. Quality Improvement Organizations (QIOs) and Hospital Quality Improvement contractors provide technical assistance to hospitals with excess readmission rates. Hospitals seeking to reduce HRRP penalties for TKA should analyze their readmission data by diagnosis category to identify the primary drivers at their institution, then implement targeted discharge and follow-up interventions aligned with those specific drivers.
DVT Prophylaxis Documentation and ACCP Guidelines
Venous thromboembolism prophylaxis following total knee arthroplasty is required by multiple clinical and regulatory frameworks. The American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines (CHEST Guideline, 10th Edition) recommend extended anticoagulation for a minimum of 10 to 14 days following TKA, with a preference for 35 days of prophylaxis when VTE risk factors are present. The ACCP guidelines are used as the basis for CMS VTE prophylaxis quality measures applicable to hospitals. Discharge instructions for TKA patients must specify the anticoagulation agent prescribed, the dose, the frequency, the duration of therapy, and the indication.
Discharge instructions must address both the pharmacological and mechanical components of DVT prophylaxis prescribed by the treating surgeon. Pharmacological options used in current orthopedic practice for TKA include aspirin, rivaroxaban (Xarelto), apixaban (Eliquis), enoxaparin (Lovenox), and warfarin, selected based on the patient's VTE risk profile and comorbidities. Mechanical prophylaxis including compression stockings or sequential compression devices may be prescribed in addition to pharmacological agents. Instructions must specify the duration of mechanical prophylaxis use and how to use the prescribed device correctly.
The anticoagulation regimen prescribed at TKA discharge must be reconciled against the patient's pre-operative medication list. Patients on preoperative anticoagulation or antiplatelet therapy require specific documentation of whether those medications have been resumed, held, or replaced by the post-operative prophylaxis regimen. Patients who were taking warfarin pre-operatively require documentation of the target INR range and the plan for resumption. Providers should document the VTE risk stratification that informed the prophylaxis selection, particularly for patients with prior VTE history, hypercoagulable disorders, or obesity, who are at elevated risk and may benefit from extended prophylaxis.
Discharge instructions should include explicit symptom escalation criteria for DVT and pulmonary embolism. DVT warning signs requiring evaluation include new or worsening calf pain, swelling, warmth, or redness in the lower extremity. Pulmonary embolism warning signs requiring emergency evaluation include sudden onset shortness of breath, chest pain, rapid heart rate, or lightheadedness. Instructions should explicitly state that these symptoms require immediate emergency evaluation and should not be managed with a routine follow-up phone call. Providing specific criteria reduces the likelihood that patients will attribute DVT or PE symptoms to expected post-operative discomfort.
Physical Therapy Progression, Wound Monitoring, and Follow-Up Documentation
Physical therapy initiation and progression protocols are a central element of TKA discharge documentation. AAOS clinical practice guidelines for TKA recovery and current rehabilitation literature support early mobilization and progressive range of motion exercises beginning in the immediate post-operative period. Discharge instructions must specify the physical therapy plan prescribed, whether inpatient rehabilitation, home physical therapy, or outpatient physical therapy, the frequency and type of exercises to be performed, range of motion goals at defined time points, and activity restrictions including weight-bearing status, use of assistive devices, and restrictions on specific activities such as stair climbing or driving.
Weight-bearing status following TKA must be clearly documented in the discharge instructions. Most contemporary TKA protocols allow immediate full weight-bearing as tolerated, but individual surgeon protocols may restrict weight-bearing in specific circumstances. The discharge instructions must state the patient's specific weight-bearing status using standard clinical terminology: full weight-bearing (FWB), weight-bearing as tolerated (WBAT), partial weight-bearing (PWB) with the percent of body weight permitted, toe-touch weight-bearing (TTWB), or non-weight-bearing (NWB). Ambiguous instructions regarding weight-bearing status increase fall risk and can delay rehabilitation progress.
Wound monitoring documentation at discharge should specify the type of wound closure used (staples, sutures, or adhesive closure), the expected timeline for wound closure device removal (typically 10 to 14 days for staples following TKA), and the criteria for wound changes requiring provider evaluation before the scheduled removal date. Signs of surgical site infection requiring provider contact include increasing wound erythema or warmth beyond the immediate peri-incisional area, purulent drainage, wound dehiscence, or fever above 101.5 degrees Fahrenheit occurring after the first 48 post-operative hours. Early identification of wound complications reduces the risk of periprosthetic joint infection, which carries a substantially higher treatment burden than superficial wound complications.
The scheduled follow-up appointment must be documented in the TKA discharge instructions. Standard TKA follow-up protocols typically include an appointment at 2 to 4 weeks post-operatively for wound evaluation and staple or suture removal, a 6-week appointment for radiographic assessment of implant positioning and rehabilitation progress review, and a 3-month appointment for functional outcome assessment. Providers should confirm the initial post-operative appointment before or at discharge and document the date, time, and location in the discharge instructions. Patients who leave the hospital without a confirmed follow-up appointment are at higher risk of delayed complication identification and preventable readmission.
How does CMS calculate the HRRP penalty for total knee arthroplasty?
CMS calculates the HRRP excess readmission ratio for TKA by comparing a hospital's risk-adjusted 30-day all-cause readmission rate to the national benchmark rate, using 3 years of Medicare fee-for-service claims data. The risk adjustment model accounts for age, sex, and comorbidities captured in Medicare claims. Hospitals with an excess readmission ratio above 1.0 receive a payment adjustment that reduces all Medicare base operating payments for the applicable fiscal year. The maximum HRRP payment reduction is 3% of base Medicare payments, regardless of the number of target conditions with excess readmission rates.
What DVT prophylaxis duration do ACCP guidelines recommend after total knee arthroplasty?
The American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines recommend a minimum of 10 to 14 days of anticoagulation prophylaxis following total knee arthroplasty, with a preference for 35 days of extended prophylaxis when VTE risk factors are present. Approved prophylaxis agents for TKA include aspirin, rivaroxaban, apixaban, enoxaparin, and warfarin, selected based on the patient's clinical risk profile. Discharge instructions must specify the agent, dose, frequency, and duration of therapy, and must include symptom criteria for DVT and pulmonary embolism that require emergency evaluation.
What weight-bearing status terms should be used in TKA discharge instructions?
Discharge instructions for TKA patients should specify weight-bearing status using standard clinical terminology to avoid ambiguity: full weight-bearing (FWB), weight-bearing as tolerated (WBAT), partial weight-bearing (PWB) with the percentage of body weight specified, toe-touch weight-bearing (TTWB), or non-weight-bearing (NWB). Instructions should also specify the required assistive device (crutches, walker, or cane), the timeline for progressing to less restrictive weight-bearing if applicable, and any specific activities restricted during the initial recovery period.
What wound monitoring instructions are required for TKA discharge?
TKA discharge instructions should specify the wound closure device used, the expected timeline for removal (typically 10 to 14 days for staples), and criteria requiring earlier provider evaluation. Signs of surgical site infection requiring contact include increasing erythema or warmth beyond the immediate peri-incisional area, purulent drainage, wound separation or dehiscence, or fever above 101.5 degrees Fahrenheit after the first 48 post-operative hours. Instructions should also include the expected appearance of a healing wound at defined post-operative timepoints so patients can distinguish normal healing from concerning changes.
For practices
Bring this to your own practice.
QR Rx turns every procedure into a branded recovery plan that keeps patients engaged and brings them back. Start free in minutes, or see it live in a 20-minute demo.
This blog provides general information about healthcare compliance and aftercare best practices. It does not constitute legal, medical, or regulatory advice. Consult qualified professionals for guidance specific to your practice.
